| Interim estimates of vaccine effectiveness of BNT162b2 and mRNA-1273 COVID-19 vaccines in preventing SARS-CoV-2 infection among health care personnel, first responders, and … MG Thompson MMWR. Morbidity and Mortality Weekly Report 70, 2021 | 818 | 2021 |
| Association between mRNA vaccination and COVID-19 hospitalization and disease severity MW Tenforde, WH Self, K Adams, M Gaglani, AA Ginde, T McNeal, ... Jama 326 (20), 2043-2054, 2021 | 583 | 2021 |
| Clinical severity of, and effectiveness of mRNA vaccines against, covid-19 from omicron, delta, and alpha SARS-CoV-2 variants in the United States: prospective observational study AS Lauring, MW Tenforde, JD Chappell, M Gaglani, AA Ginde, T McNeal, ... bmj 376, 2022 | 516 | 2022 |
| Prevention and attenuation of Covid-19 with the BNT162b2 and mRNA-1273 vaccines MG Thompson, JL Burgess, AL Naleway, H Tyner, SK Yoon, J Meece, ... New England Journal of Medicine 385 (4), 320-329, 2021 | 510 | 2021 |
| Comparative effectiveness of Moderna, Pfizer-BioNTech, and Janssen (Johnson & Johnson) vaccines in preventing COVID-19 hospitalizations among adults without immunocompromising … WH Self MMWR. Morbidity and mortality weekly report 70, 2021 | 461 | 2021 |
| Effectiveness of Covid-19 vaccines in ambulatory and inpatient care settings MG Thompson, E Stenehjem, S Grannis, SW Ball, AL Naleway, TC Ong, ... New England Journal of Medicine 385 (15), 1355-1371, 2021 | 452 | 2021 |
| Waning 2-dose and 3-dose effectiveness of mRNA vaccines against COVID-19–associated emergency department and urgent care encounters and hospitalizations among adults during … JM Ferdinands MMWR. Morbidity and mortality weekly report 71, 2022 | 439 | 2022 |
| Effectiveness of a third dose of mRNA vaccines against COVID-19–associated emergency department and urgent care encounters and hospitalizations among adults during periods of … MG Thompson MMWR. Morbidity and mortality weekly report 71, 2022 | 438 | 2022 |
| Influenza vaccine effectiveness in the 2011–2012 season: protection against each circulating virus and the effect of prior vaccination on estimates SE Ohmit, MG Thompson, JG Petrie, SN Thaker, ML Jackson, ... Clinical infectious diseases 58 (3), 319-327, 2014 | 390 | 2014 |
| Effectiveness of school-based influenza vaccination JC King Jr, JJ Stoddard, MJ Gaglani, KA Moore, L Magder, E McClure, ... New England Journal of Medicine 355 (24), 2523-2532, 2006 | 345 | 2006 |
| Herd immunity in adults against influenza-related illnesses with use of the trivalent-live attenuated influenza vaccine (CAIV-T) in children PA Piedra, MJ Gaglani, CA Kozinetz, G Herschler, M Riggs, M Griffith, ... Vaccine 23 (13), 1540-1548, 2005 | 345 | 2005 |
| Effectiveness of COVID-19 vaccines in preventing SARS-CoV-2 infection among frontline workers before and during B. 1.617. 2 (Delta) variant predominance—eight US locations … A Fowlkes MMWR. Morbidity and Mortality Weekly Report 70, 2021 | 327 | 2021 |
| Influenza vaccine effectiveness in the United States during 2012–2013: variable protection by age and virus type HQ McLean, MG Thompson, ME Sundaram, BA Kieke, M Gaglani, ... The Journal of infectious diseases 211 (10), 1529-1540, 2015 | 319 | 2015 |
| Influenza vaccine effectiveness in the United States during the 2015–2016 season ML Jackson, JR Chung, LA Jackson, CH Phillips, J Benoit, AS Monto, ... New England Journal of Medicine 377 (6), 534-543, 2017 | 309 | 2017 |
| Effects of influenza vaccination in the United States during the 2017–2018 influenza season MA Rolfes, B Flannery, JR Chung, A O’Halloran, S Garg, EA Belongia, ... Clinical Infectious Diseases 69 (11), 1845-1853, 2019 | 280 | 2019 |
| 2014–2015 influenza vaccine effectiveness in the United States by vaccine type RK Zimmerman, MP Nowalk, J Chung, ML Jackson, LA Jackson, ... Clinical Infectious Diseases, ciw635, 2016 | 279 | 2016 |
| Early estimates of seasonal influenza vaccine effectiveness-United States, January 2015 B Flannery, J Clippard, RK Zimmerman, MP Nowalk, ML Jackson, ... MMWR Morb Mortal Wkly Rep 64 (1), 10-5, 2015 | 257 | 2015 |
| Sustained effectiveness of Pfizer-BioNTech and Moderna vaccines against COVID-19 associated hospitalizations among adults—United States, March–July 2021 MW Tenforde MMWR. Morbidity and mortality weekly report 70, 2021 | 249 | 2021 |
| Interim estimates of 2017–18 seasonal influenza vaccine effectiveness—United States, February 2018 B Flannery MMWR. Morbidity and mortality weekly report 67, 2018 | 214 | 2018 |
| Influenza vaccine effectiveness against 2009 pandemic influenza A (H1N1) virus differed by vaccine type during 2013–2014 in the United States M Gaglani, J Pruszynski, K Murthy, L Clipper, A Robertson, M Reis, ... The Journal of infectious diseases 213 (10), 1546-1556, 2016 | 194 | 2016 |
Edward BelongiaMarshfield Clinic Research InstituteVerified email at marshfieldclinic.org
